Warning: This data is provided for information purpose only. You should not start or stop any medication without consulting your care giver.
Use the Health Monitor application at http://www.healthsupportsystems.com to search for a drug by brand, generic or symptom
SEMPREX-D
Active Ingredients
ACRIVASTINE,PSEUDOEPHEDRINE HYDROCHLORIDE
Inctive Ingredients
n/a
Usage
SEMPREX-D Capsules are indicated for relief of symptoms associated with seasonal allergic rhinitis such as sneezing, rhinorrhea, pruritus, lacrimation, and nasal congestion. SEMPREX-D Capsules should be administered when both the antihistaminic activity of acrivastine and the nasal decongestant activity of pseudoephedrine are desired (see CLINICAL PHARMACOLOGY). The efficacy of SEMPREX-D Capsules beyond 14 days of continuous treatment in patients with seasonal allergic rhinitis has not been adequately investigated in clinical trials.
SEMPREX-D Capsules have not been adequately studied for effectiveness in relieving the symptoms of the common cold.